Water Molecules Increases Binding Affinity of Natural PI3Kγ Inhibitors Against Cancer

Pooja Sharma, Aparna Shukla, Komal Kalani

  • 1Metabolic & Structural Biology Department, CSIR-Central Institute of Medicinal & Aromatic Plant, P.O.- CIMAP, Kukrail Picnic Spot Road, Lucknow-226015 (U.P.) India. f.khan@cimap.res.in.

Insights

Including water molecules in docking simulations enhances the binding affinity of Phosphoinositide 3-kinase (PI3K) inhibitors. This study investigated PI3K targets, revealing water

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology and Drug Discovery
  • Computational Chemistry

Background:

  • The Phosphoinositide 3-kinase (PI3K) pathway is crucial for cellular functions, including survival, protein synthesis, and metabolism.
  • Dysregulation of the PI3K pathway is implicated in various cancers, making it a significant target for therapeutic intervention.
  • Understanding inhibitor binding to PI3K targets is essential for developing effective anticancer drugs.

Purpose of the Study:

  • To investigate the influence of water molecules on the binding orientation of PI3K inhibitors.
  • To compare molecular docking results with crystallographic data, considering the presence and absence of water molecules.
  • To evaluate the potential anticancer activity of serpentine as a PI3K inhibitor.

Main Methods:

  • Employed molecular docking using AutoDock v4.2 to study PI3Kγ and its inhibitors (wortmannin, quercetin, myricetin, pyridyl-triazine, and serpentine).
  • Performed docking simulations in both the presence and absence of water molecules within the binding pocket.
  • Evaluated anticancer activity of serpentine through in vitro experiments.

Main Results:

  • Docking studies revealed that the inclusion of water molecules in the binding pocket increases the binding affinity of PI3K inhibitors.
  • Comparison of docking results with crystallographic data, considering binding energy, RMSD, and inhibition constant (Ki), supports the role of water molecules.
  • Conserved and bridging water molecules play a significant role in enhancing inhibitor binding to PI3K targets.

Conclusions:

  • Water molecules are critical for accurately modeling inhibitor binding to PI3K targets.
  • Incorporating water molecules into docking protocols can improve the prediction of drug binding affinity and orientation.
  • This finding has implications for the rational design of novel PI3K inhibitors with enhanced efficacy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.5K